Additionally, the 36-month beta value for MYNZ is 0.21. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0
In the past week, MYNZ stock has gone down by -28.82%, with a monthly decline of -52.66% and a quarterly plunge of -56.86%. The volatility
Mainz Biomed N.V (NASDAQ: MYNZ) has experienced a decline in its stock price by -12.17 compared to its previous closing price of 6.00. However, the
The 36-month beta value for MYNZ is at 0.06. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0
Mainz Biomed N.V (NASDAQ: MYNZ)’s stock price has dropped by -14.02 in relation to previous closing price of 0.26. Nevertheless, the company has seen a
The stock has a 36-month beta value of 0.04. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 1 as
The stock of Mainz Biomed N.V (MYNZ) has seen a 0.74% increase in the past week, with a -28.54% drop in the past month, and
The 36-month beta value for MYNZ is also noteworthy at 0.05. There are mixed opinions on the stock, with 1 analysts rating it as a
© 2024, Powered by Smart TechOne
